TheraVet (ISIN: BE0974387194 - ticker: ALVET) today announces a strategic transformation project with H4Orphan aimed at ...

This blog describes a typical ILD patient journey from the initial diagnosis through its long-term management to end-of-life ...

Garadacimab is under clinical development by CSL and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase II drugs for Idiopathic Pulmonary Fibrosis have a 35% phase ...

RFS is progressive, meaning it will generally get worse without treatment. Symptoms of RFS may be: Muscle weakness Neuropathy (pain from damaged nerves) Muscle pain, spasm, or tightness If pulmonary ...

There may also be extraesophageal manifestations of GERD, such as mouth ulcers, chronic cough, pharyngitis, laryngospasm, asthma, and (most severely) aspiration pneumonia and pulmonary fibrosis.

If you experience any of the following symptoms, seek immediate medical attention to rule out more serious possible causes of your pain like a heart attack or pulmonary embolism: Heartburn, acid ...

Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...

Background A usual interstitial pneumonia (UIP) pattern of lung injury is a key feature of idiopathic pulmonary fibrosis (IPF) and is also observed in up to 40% of individuals with rheumatoid ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...